This is nonsense, merger needs to be approved by Livent and Allkem shareholders, how can they approve it but at the same time say they are worst off. If they think Livent shareholders are worst off, they should not agree to this merger, simple.
AKE Price at posting:
$15.96 Sentiment: Buy Disclosure: Held